Bioniche Announces E. coli Vaccine to Be Used for Study in Sweden

Bioniche Life Sciences Inc (TSX:BNC, ASX:BNC) announced that its E.coli O157 cattle vaccine will be shipped to Sweden for on-farm studies involving cattle herds.

As quoted in the press release:

Sweden has been testing and monitoring both cattle farm and slaughterhouse samples for verotoxigenic E. coli (VTEC) for more than three years. The results of this testing have been correlated to human illness due to VTEC. While more than one type of VTEC has been associated with human illness in Sweden, a particular sub-group of the O157 strain, clade 8, has consistently been associated with the most severe cases of human illness in that country.

Click here to read the full Bioniche Life Sciences Inc (TSX:BNC, ASX:BNC) press release.